Status:
COMPLETED
To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.
Lead Sponsor:
Pfizer
Conditions:
Seizure Disorder, Partial
Eligibility:
All Genders
12+ years
Phase:
PHASE3
Brief Summary
To evaluate the long-term safety and tolerability of pregabalin in patients with partial seizures.
Eligibility Criteria
Inclusion
- Must have met the inclusion criteria for preceding double-blind study
- Have received double-blind study medication and wish to receive open-label pregabalin.
Exclusion
- Cannot have absence seizures
Key Trial Info
Start Date :
November 1 1999
Trial Type :
INTERVENTIONAL
End Date :
July 1 2005
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT00141336
Start Date
November 1 1999
End Date
July 1 2005
Last Update
January 1 2007
Active Locations (103)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Phoenix, Arizona, United States, 85013
2
Pfizer Investigational Site
Tucson, Arizona, United States, 85724
3
Pfizer Investigational Site
Bakersfield, California, United States, 93301
4
Pfizer Investigational Site
Berkeley, California, United States, 94705